Stanford Medcast puts you in the front row at some of the leading-edge lectures at the School of Medicine. Tune in to watch Stanford faculty and other renown experts discuss the latest advances in biomedical research, patient care and other health-related fields.
Lectures
-
favorites
Lecture 1 - Is Evidence-Based Medicine a Barrier to Cost-Effective Care?
Alan Garber, MD, PhD, professor of medicine and the director of the Center for Health Policy and of the Center for Primary Care and Outcomes Research at Stanford University, discusses the importance of distinguishing between a treatment's effectiveness and its value, and in turn what role evidence-based medicine should play in today's coverage decisions.
-
favorites
Lecture 2 - Monoclonal Antibodies: Stanford Academia-Industry Collaboration
Ron Levy, MD, professor of Medicine at Stanford, recounts his experiences moving his discovery from the lab to the clinical setting and discusses the future of this cancer treatment. Wendy Harpham, a participant in the early clinical trials of Rituxan, the first FDA-approved monoclonal antibody for cancer treatment that Levy developed, provides a patient's perspective.
-
favorites
Lecture 3 - The Battle of the Diets: Is Anyone Winning (At Losing?)
The case for low-carbohydrate diets is gaining weight. Christopher Gardner, PhD, assistant professor of medicine at the Stanford Prevention Research Center, has completed the largest and longest-ever comparison of four popular diets using real-world conditions, which he discusses - the lowest-carbohydrate Atkins diet came out on top.
-
favorites
Lecture 4 - The Mismeasure of Man
Ralph Horwitz, MD, professor of medicine at Stanford discusses how measurement can both strengthen and weaken clinical science and care. Often overlooked amid today's enthusiasm for quantifiable results, he says, are the real complexities of medicine.
-
favorites
Lecture 5 - New Perspectives on Menopausal Hormones and Heart Disease
Recent Women's Health Initiative (WHI) studies demonstrated that hormone therapy carries a number of health risks in woman not considered earlier, such as the increased likelihood of blood clots and stroke. Marcia Stefanick, PhD, professor of medicine at Stanford School of Medicine, served as chair of the WHI steering committee and she continues to analyze the project's data for other ill-effects.
